| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |